FDA Inspection
David L. Wirta, M.D.David L. Wirta, M.D. – FDA Inspection, Aug 13, 2021
Record Details
This FDA Inspection record concerns David L. Wirta, M.D., with an inspection on August 13, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- David L. Wirta, M.D.
- Inspection Date
- August 13, 2021
- Product Type
- Drugs
View Company Profile
ID · 43459b12-5bf3-4b40-bc48-590187106458
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1148850
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of David L. Wirta, M.D.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2025 | Not classified | Los Angeles District Office | |
| March 6, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 6, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 20, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 19, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for David L. Wirta, M.D.
- FDA Inspection 1275380 - 2025-06-27
- FDA Inspection 1263477 - 2025-03-06
- FDA Inspection 1202557 - 2023-04-06
- FDA Inspection 949042 - 2015-11-20
- FDA Inspection 725277 - 2011-05-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.